Press Release RSS Feed (opens in new window)
Press release year list 2023 2022 2021 2020 2019 2018 2017 2016
12/21/2017
Tetra Bio-Pharma Announces the Signature of a Letter of Intent to Monetize GrowPros and its Late Stage ACMPR Application
12/13/2017
Tetra Bio-Pharma Reinforces its Development Program by Signing Research & Development Agreement with Constance Therapeutics and Receiving Financial Support from NSERC
12/09/2017
Tetra Bio-Pharma provides update on status of its Phase 3 Clinical Trial Application of Lead Drug Candidate PPP001
12/06/2017
Tetra Bio-Pharma Opens Markets at TSX Listing Ceremony
11/28/2017
Tetra Bio-Pharma accelerates submission of New Drug Application to FDA & Expects to Commercialize Dronabinol XL Tablet Ahead of Schedule(1) in the US
11/22/2017
Tetra Bio-Pharma's Business Model and Commercialization Strategy In Line with the Canadian Government's Proposed Approach to the Regulation of Cannabis
11/16/2017
Tetra Bio-Pharma Inc.: Rx Princeps(TM) Now Available for Patients through Licenced Producer Partner Aphria
11/09/2017
Tetra Bio-Pharma Concludes its First Sale of Rx Princeps(TM) Inhalation Device
10/26/2017
Tetra Bio-Pharma Goes After the Cannabis Oil Medical Market and Launches a Phase 4 Trial with Cannabis Oils in Partnership with Santé Cannabis
10/19/2017
Tetra Bio-Pharma Hires Medical Science Liaison to Promote Rx Princeps(TM) and Presents its New Corporate Image
10/18/2017
Tetra Bio-Pharma Signs Agreement with Partner Aphria to Start Promoting Rx Princeps(TM), its Medical Cannabis Blend, under ACMPR
10/13/2017
Tetra Bio-Pharma Continues Forward into the Veterinary Ophthalmology Market by Entering into an Agreement with Drs. Cullen and Webb
10/04/2017
Tetra Bio-Pharma Selected to Present at Prestigious BIO Investor Forum In San Francisco October 17-18
09/28/2017
Tetra Engages in Innovative Air Analysis and Development of Specific Air Cleaning Devices with AES Environment for the Commercialization of PPP001 and for Marijuana Consumer Market
09/20/2017
Tetra Bio-Pharma to engage in co-development and distribution partnership with major healthcare specialty distributor
09/18/2017
Tetra Bio-Pharma getting ready to file a clinical trial application to initiate phase 3 clinical trial on terminal cancer patients in the coming weeks
09/11/2017
Tetra Bio-Pharma accelerates its clinical research program in the veterinary market by entering into agreement with Dr. Louis-Philippe de Lorimier
09/07/2017
Tetra Bio-Pharma to Attend the 10th Annual International Partnering Conference - BioPharm America
08/31/2017
Tetra Bio-Pharma to Benefit from Intellectual Properties Created within the Cannabis Health Research Chair from the University of New Brunswick
08/29/2017
Tetra Bio-Pharma Strengthens its Management Team in Preparation for the Initiation of its Commercial Activities
Download PDF format download (opens in new window)
08/28/2017
Tetra Bio-Pharma’s Clinical Research Partner, Altasciences, offers Innovative Cannabis Research Solutions
Download PDF format download (opens in new window)
08/16/2017
Tetra Bio-Pharma Announces Approval to List on the TSX Venture Exchange
07/25/2017
Tetra Bio-Pharma Announces Stock Option Grant to CEO
07/24/2017
Tetra Bio-Pharma Accelerates Growth Strategy with Appointment of Bernard Fortier as CEO
07/19/2017
Tetra Bio-Pharma Signs Letter of Intent with Constance Therapeutics
07/11/2017
Tetra Bio-Pharma Announces Results of Voting at Annual Shareholders' Meeting & Provides a Corporate Update
07/05/2017
Tetra Bio-Pharma Strengthens its Position on Bringing Marijuana to Patients in a Form Acceptable to Health Care Professionals
06/28/2017
Tetra Bio-Pharma Expands Focus of Commercialization Activities into the Lucrative Veterinary Market
06/14/2017
Tetra Bio-Pharma Appoints Aphria CFO, Mr. Carl Merton to the Board of Directors
06/13/2017
Tetra Bio-Pharma Announces UNB Cannabis Health Research Chair
06/07/2017
Tetra Bio-Pharma Announces the Completion of its Phase 1 Safety Report to Health Canada and Launches the Preparation of a Phase III Clinical Trial for PPP001 with Sante Cannabis
05/30/2017
Tetra Bio-Pharma Strengthens its Board with the Appointment of Dr. Bill Cheliak
05/23/2017
Tetra Bio-Pharma Signs Definitive Agreement for Two Products with Panag Pharma
05/17/2017
Tetra Bio-Pharma Files Patent for the Treatment of Cancer and Ocular Disease
05/11/2017
Tetra Bio-Pharma Strengthens Management Team
Download PDF format download (opens in new window)
04/24/2017
Tetra Bio-Pharma Accelerates Sales Strategy with the Appointment of Denis Courchesne as Vice President, Sales
Download PDF format download (opens in new window)
04/19/2017
Tetra Bio-Pharma & Aphria Announce Plans for the Joint Distribution of Dried Medical Cannabis in the Maritime Provinces & Quebec
Download PDF format download (opens in new window)
04/12/2017
Tetra Bio-Pharma Announces the Opening of a New Brunswick Office for Manufacturing & Sales Activities
Download PDF format download (opens in new window)
04/05/2017
Tetra Bio-Pharma Upgrades to OTCQB to Engage and Expand U.S. Investor Audience
Download PDF format download (opens in new window)
04/03/2017
Tetra Bio-Pharma and IntelGenx Announce the Signing of a Definitive Agreement for the Development and Commercialization of a Dronabinol XL Tablet
Download PDF format download (opens in new window)
03/27/2017
Tetra Bio-Pharma Appoints Edward Miller as Vice President, Investor Relations & Corporate Communications
Download PDF format download (opens in new window)
03/20/2017
Aphria Exercises Warrants for Gross Proceeds of $1.3 Million to Further Fund Tetra’s Clinical Trials
Download PDF format download (opens in new window)
03/14/2017
Tetra Bio-Pharma Enters into Binding Term Sheet For Two Products with Panag Pharma
Download PDF format download (opens in new window)
03/09/2017
Tetra Bio-Pharma Announces that the Delay in Legalization of Marijuana Does Not Affect its Drug Development & Commercialization Plans
Download PDF format download (opens in new window)
02/24/2017
Tetra Bio-Pharma Grants Stock Options
Download PDF format download (opens in new window)
02/23/2017
Tetra Bio-Pharma Announces the Initiation of its Phase I Trial of PPP001 (dried Cannabis)
Download PDF format download (opens in new window)
02/16/2017
Tetra Bio-Pharma Reports Approval by Health Canada of its Phase I Trial of PPP001 (dried Cannabis)
Download PDF format download (opens in new window)
02/09/2017
Tetra Bio-Pharma and IntelGenx Announce the Signing of a Term Sheet for the Development and Commercialization of a Dronabinol XL Tablet
Download PDF format download (opens in new window)
02/06/2017
Tetra Bio-Pharma Inc. Enters into Distribution and Supply Agreement with Engen Medical Corporation
Download PDF format download (opens in new window)
02/01/2017
Tetra Bio-Pharma Inc. Receives Notice of Authorization from Health Canada for the Conduct of its Clinical Trial with its PPTGR Topical Product
Download PDF format download (opens in new window)
01/30/2017
Tetra Bio-Pharma Inc. Completes Pre-IND Meeting with Food and Drug Administration on PPP001
Download PDF format download (opens in new window)
01/23/2017
Tetra BioPharma Announces it Has Entered into a Clinical Research Partnership with Santé Cannabis, Québec’s Leading Medical Cannabis Institution
Download PDF format download (opens in new window)
01/11/2017
Tetra Bio-Pharma Inc. annonce une nouvelle nomination à son conseil consultatif scientifique et clinique
Download PDF format download (opens in new window)
01/11/2017
Tetra Bio-Pharma Inc. Announces A New Appointment to its Scientific and Clinical Advisory Board
Download PDF format download (opens in new window)
01/10/2017
Tetra Bio-Pharma Inc. Enters into Binding Letter of Intent for Co-Development and Commercialization of Health Care Products Containing Cannabinoids and Closes a Private Placement
Download PDF format download (opens in new window)